Skip to main content
NCBI home page
Wiley - PMC COVID-19 Collection logoLink to Wiley - PMC COVID-19 Collection
. 2005 Dec 6;9(2):149–158. doi: 10.1002/jmv.1890090210

Appearance of complement components and immunoglobulins on nasopharyngeal epithelial cells following naturally acquired infection with respiratory syncytial virus

Tej N Kaul 1,✉, Robert C Welliver 1, Pearay L Ogra 1
PMCID: PMC7166695  PMID: 7069409

Abstract

Nasopharyngeal epithelial cells (NPEC) were collected from 144 infants and children with respiratory syncytial virus (RSV) infection, and were analyzed by fluorescent antibody techniques for the presence of cell‐bound complement (C/ 3), IgA, IgC, and IgM class of immunoglobulins (Ig), and respiratory syncytial virus antigen. Viral antigen was present on the surface of NPEC in 100% of samples obtained in the first 3 days of illness. The percentage of patients positive for RSV antigen declined steadily, so that no patient still expressed viral antigen on NPEC by 57 days after the onset of illness. Cell‐bound IgA, IgC, and IgM could be detected in most of the samples tested in the first 13 days after the onset of illness. Subsequently, the frequency of detection of cell‐bound Ig gradually declined. Only 8–3 3 % of patients tested 57 days after the onset of illness expressed IgA, IgG, or IgM on NPEC. About 45% of samples tested in the first 8 weeks after the onset of illness exhibited complement binding to NPEC. The percentage of subjects showing cell‐bound C/ 3 reached a maximum at 8–13 says after the onset of illness, while cell–bound C/3 could not be detected in any of the samples collected 57–90 days after the onset of illness. Although cell‐bound C/ 3 was generally present in association with cell‐bound Ig on NPEC, in a small percentage (4.6%) of patients cell‐bound C/3 could be detected in the absence of any cell–bound Ig. Cell‐bound C/3 and IgA, IgG, and IgM were present with equal frequency in patients with all forms of clinical disease caused by RSV, and in patients less than or greater than 6 months of age at the onset of illness.

Keywords: respiratory syncytial virus, complement, secretary antibody

References

  1. Chanock RM, Kapikian AZ, Mills J, Kim HW, Parrott RH (1970). Influence of immunologic factors in Respiratory Syncytial Virus disease of the lower respiratory tract. Archives of Environmental Health 21: 347–355. [DOI] [PubMed] [Google Scholar]
  2. Cooper NR, Jensen FC, Welsh RM, Oldstone MBA (1976). Lysis of RNA tumor viruses by human serum: Direct antibody independent triggering of the classical complement pathway. Journal of Experimental Medicine 144: 970–1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Dowdle WR, Downie JC, Laver WG (1974). Inhibition of virus release by antibodies to surface antigens of influenza viruses. Journal or Virology 13: 269–275. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Frank MM (1979). Complement system in host defense and inflammation. Reviews of Infectious Diseases 1: 483–501. [DOI] [PubMed] [Google Scholar]
  5. Gardner PS, McQuillin J, Court SDM (1970). Speculation on pathogenesis, in death from Respiratory Syricytiai Virus infection. British Medical Journal 1: 327–330. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Gardner PS, McQuillin J (1978). The coating of respiratory synctial (RS) virus infected cells in the respiratory tract by imniunoglobulins. Journal of Medical Virology 2: 165–173. [DOI] [PubMed] [Google Scholar]
  7. Grewal AS, Babiuk LA (1980). Complement‐dependent‐polymorphonuclear mediated cytotoxicity of herpes virus‐infected cells: Possible mechanism of cytotoxicity. Immunology 40: 151–161. [PMC free article] [PubMed] [Google Scholar]
  8. Grewal AS, Rouse BT, Babiuk LA (1980). Mechanisms of recovery from viral infections: Destruction of infected cells by neutrophils and complement. Journal of Immunology 124: 312–319. [PubMed] [Google Scholar]
  9. Hicks JT, Ennis FA, Kim E, Vernomitz M (1978). The importance of an intact complement pathway in recovery from primary viral infection: Influenza in decomplimented and in C5‐deficient mice. Journal of Immunology 121: 1437–1445. [PubMed] [Google Scholar]
  10. Hirsh RL, Winkelstein JA, Erittin DE (1980a). Role of complement in viral infections. Activation of classical and alternate complenient pathways by Sindbis virus. Journal of Immunology 124: 2507–2510. [PubMed] [Google Scholar]
  11. Hirsh RL, Griffin DE, Winkelsteiri JA (1980b). The role of cornplement in viral infections. II. The clearance of Sindbis virus from the blood‐btream and central nervous system of mice depleted of complement. Journal of Infectious Diseases 141: 212–217. [DOI] [PubMed] [Google Scholar]
  12. Kaul A, Scott R, Callagher M, Scott M, Clement J, Ogra PL (1978). Respiratory syncytial virus infection: Rapid diagnosis in children by use of indirect immunofluorescence. American Journal of Diseases of Children 132: 1088–1090. [DOI] [PubMed] [Google Scholar]
  13. Kaul TN, Welliver RC, Ogra PL (1981a). Comparison of fluorescent‐antibody, neutralizing antibody and complement‐enhanced neutralizing antibody assays for detection of serum antibody to respiratory syncytial virus. Journal of Clinical Microbiology 13: 957–962. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Kaul TN, Welliver RC, Wong DT, Udwadia RA, Riddlesberger K, Ogra PL (1981b). Secretory antibody response to primary and secondary infection with respiratory syncytial virus. American Journal of Disease of Children, 135: 1013–1016. [DOI] [PubMed] [Google Scholar]
  15. Lennette EH, Schmidt NJ (1969). Diagnostic Procedures for Viral and Rickettyial Infections. 4 th ed New York: American Public Health Association. [Google Scholar]
  16. McIntosh K, Masters HB, Orr I, Chao RK, Barkin RM (1978). The immunological response to rcspiratory syncytial virus infection in infants. Journal of Infectious Diseascs 138: 24–32. [DOI] [PubMed] [Google Scholar]
  17. McIntosh K, McQuillin J, Gardner PS (1979). Cell‐free and cell bound antibody in nasal secretions from infants with respiratory syncytial virus infection. Infection and Immunity 23: 276–281. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Mills BJ, Cooper NR (1978). Antibody‐independent neutralization of vesicular stomatitis virus by human complement. I. Complement requirements. Journal of Immunology 121: 1549–1557. [PubMed] [Google Scholar]
  19. Okada N, Shibuta H, Okada H (1979). Activation of alternate pathway of Guinea pig complement by Sendai virus‐treated cells. Microbiology Immunology 23: 689–692. [DOI] [PubMed] [Google Scholar]
  20. Welliver RC, Kaui A, Ogra PL (1979). Cell mediated immune response to respiratory syncytial virus infection: Relationship to the development of reactive airway disease. Jaurnal of Pediatrics 94: 370–375. [DOI] [PubMed] [Google Scholar]
  21. Weiliver RC, Kaul TN, Ogra PL (1980). The appearance of cell‐bound IgE in respiratory tract epithelium after respiratory syncytial virus infection. New England Journal of Medicine 303: 1198–1202. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Medical Virology are provided here courtesy of Wiley

RESOURCES